Abstract
The incidence of differentiated thyroid cancer has been increasing. Nevertheless, its molecular mechanisms are not well understood. In recent years, extracellular nucleotides and nucleosides have emerged as important modulators of tumor microenvironment. Extracellular ATP is mainly hydrolyzed by NTPDase1/CD39 and NTPDase2/CD39L1, generating AMP, which is hydrolyzed by ecto-5′-nucleotidase (CD73) to adenosine, a possible promoter of tumor growth and metastasis. There are no studies evaluating the expression and functionality of these ectonucleotidases on normal or tumor-derived thyroid cells. Thus, we investigated the ability of thyroid cancer cells to hydrolyze extracellular ATP generating adenosine, and the expression of ecto-enzymes, as compared to normal cells. We found that normal thyroid derived cells presented a higher ability to hydrolyze ATP and higher mRNA levels for ENTDP1–2, when compared to papillary thyroid carcinoma (PTC) derived cells, which had a higher ability to hydrolyze AMP and expressed CD73 mRNA and protein at higher levels. In addition, adenosine induced an increase in proliferation and migration in PTC derived cells, whose effect was blocked by APCP, a non-hydrolysable ADP analogue, which is an inhibitor of CD73. Taken together, these results showed that thyroid follicular cells have a functional purinergic signaling. The higher expression of CD73 in PTC derived cells might favor the accumulation of extracellular adenosine in the tumor microenvironment, which could promote tumor progression. Therefore, as already shown for other tumors, the purinergic signaling should be considered a potential target for thyroid cancer management and treatment.
Similar content being viewed by others
References
Omry-Orbach G (2016) Risk stratification in differentiated thyroid cancer: an ongoing process. Rambam Maimonides Med J 7(1):e0003. https://doi.org/10.5041/RMMJ.10230
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13:45. https://doi.org/10.1186/s12916-015-0278-7
Braganhol E, Morrone FB, Bernardi A, Huppes D, Meurer L, Edelweiss MI, Lenz G, Wink MR, Robson SC, Battastini AM (2009) Selective NTPDase2 expression modulates in vivo rat glioma growth. Cancer Sci 100(8):1434–1442. https://doi.org/10.1111/j.1349-7006.2009.01219.x
Morrone FB, Oliveira DL, Gamermann P, Stella J, Wofchuk S, Wink MR, Meurer L, Edelweiss MI, Lenz G, Battastini AM (2006) In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6:226. https://doi.org/10.1186/1471-2407-6-226
Wink MR, Lenz G, Braganhol E, Tamajusuku AS, Schwartsmann G, Sarkis JJ, Battastini AM (2003) Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 198(2):211–218
Buffon A, Ribeiro VB, Wink MR, Casali EA, Sarkis JJ (2007) Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: molecular identification, kinetic characterization and biochemical properties. Life Sci 80(10):950–958. https://doi.org/10.1016/j.lfs.2006.11.024
Buffon A, Wink MR, Ribeiro BV, Casali EA, Libermann TA, Zerbini LF, Robson SC, Sarkis JJ (2007) NTPDase and 5′ ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor. Biochim Biophys Acta 1770(8):1259–1265. https://doi.org/10.1016/j.bbagen.2007.05.004
Tamajusuku AS, Villodre ES, Paulus R, Coutinho-Silva R, Battasstini AM, Wink MR, Lenz G (2010) Characterization of ATP-induced cell death in the GL261 mouse glioma. J Cell Biochem 109(5):983–991. https://doi.org/10.1002/jcb.22478
Di Virgilio F, Adinolfi E (2016) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36:293–303. https://doi.org/10.1038/onc.2016.206
Zimmermann H, Zebisch M, Strater N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8(3):437–502. https://doi.org/10.1007/s11302-012-9309-4
Kondo T, Nakazawa T, Murata SI, Katoh R (2006) Expression of CD73 and its ecto-5′-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 48(5):612–614. https://doi.org/10.1111/j.1365-2559.2005.02277.x
Tanaka J, Ogura T, Sato H, Hatano M (1987) Establishment and biological characterization of an in vitro human cytomegalovirus latency model. Virology 161(1):62–72
Challeton C, Branea F, Schlumberger M, Gaillard N, de Vathaire F, Badie C, Antonini P, Parmentier C (1997) Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys 37(1):163–169
Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G (1987) One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7(9):3365–3370
Ambesi-Impiombato FS, Parks LA, Coon HG (1980) Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci U S A 77(6):3455–3459
Naasani LI, Rodrigues C, de Campos RP, Beckenkamp LR, Iser IC, Bertoni AP, Wink MR (2017) Extracellular nucleotide hydrolysis in dermal and Limbal mesenchymal stem cells: a source of adenosine production. J Cell Biochem 118:2430–2442. https://doi.org/10.1002/jcb.25909
Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329–333. https://doi.org/10.1038/nprot.2007.30
Wang R, Zhang Y, Lin X, Gao Y, Zhu Y (2017) Prognositic value of CD73-adenosinergic pathway in solid tumor: a meta-analysis and systematic review. Oncotarget 8(34):57327–57336. https://doi.org/10.18632/oncotarget.16905
Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di Virgilio F, Monzani F (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 149(1):389–396. https://doi.org/10.1210/en.2007-1223
Wink MR, Tamajusuku AS, Braganhol E, Casali EA, Barreto-Chaves ML, Sarkis JJ, Battastini AM (2003) Thyroid hormone upregulates ecto-5′-nucleotidase/CD73 in C6 rat glioma cells. Mol Cell Endocrinol 205(1–2):107–114
Tamajusuku AS, Carrillo-Sepulveda MA, Braganhol E, Wink MR, Sarkis JJ, Barreto-Chaves ML, Battastini AM (2006) Activity and expression of ecto-5′-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells. Mol Cell Biochem 289(1–2):65–72. https://doi.org/10.1007/s11010-006-9148-0
Bastomsky CH, Zakarija M, McKenzie JM (1971) Thyroid hydrolysis of cyclic AMP as influenced by thyroid gland activity. Biochim Biophys Acta 230(2):286–295
Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A 98(26):15044–15049. https://doi.org/10.1073/pnas.251547398
Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E, Chiappetta G, Parente L, Pinto A (2008) Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Cancer Biol Ther 7(2):278–284
Goffard JC, Jin L, Mircescu H, Van Hummelen P, Ledent C, Dumont JE, Corvilain B (2004) Gene expression profile in thyroid of transgenic mice overexpressing the adenosine receptor 2a. Mol Endocrinol 18(1):194–213. https://doi.org/10.1210/me.2003-0249
Zhang L, Xu J, Sun N, Cai H, Ren M, Zhang J, Yu C, Wang Z, Gao L, Zhao J (2013) The presence of adenosine A2a receptor in thyrocytes and its involvement in Graves’ IgG-induced VEGF expression. Endocrinology 154(12):4927–4938. https://doi.org/10.1210/en.2012-2258
Zeiser R, Robson SC, Vaikunthanathan T, Dworak M, Burnstock G (2016) Unlocking the potential of purinergic signaling in transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 16(10):2781–2794. https://doi.org/10.1111/ajt.13801
Acknowledgements
We thank Dr. Ana Luiza Silva Maia (UFRGS-HCPA, Porto Alegre, Brazil) for providing the K1 and TPC-1 cells lines, and Dr. Denise Pires de Carvalho (UFRJ, Rio de Janeiro, Brazil) for providing Nthy-1, FRTL-5 and PCCL3 cells.
Funding
APSB was supported by a post doc fellowship from CAPES/PNPD (Programa Nacional de Pós-Doutorado); EB, MRW and TWF are recipients of research fellowship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). This study was supported by CNPq, Novas Terapias Portadoras de Futuro (457394/2013–7); CAPES-PROBITEC (004/2012) and PROCAD (158819); ICGEB (405231/2015–6 MCTI/CNPq-ICGEB); FIPE/HCPA (N° 15–0590); and Fundação de Amparo à Pesquisa do Rio Grande do Sul (Pronex FAPERGS/CNPq 16/2551–0000473-0).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
No conflicts of interest, financial or otherwise, are declared by the authors.
Rights and permissions
About this article
Cite this article
Bertoni, A.P.S., de Campos, R.P., Tsao, M. et al. Extracellular ATP is Differentially Metabolized on Papillary Thyroid Carcinoma Cells Surface in Comparison to Normal Cells. Cancer Microenvironment 11, 61–70 (2018). https://doi.org/10.1007/s12307-018-0206-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12307-018-0206-4